Xvivo Perfusion: Q3 expectations

Research Note

2019-10-23

05:50

Xvivo is scheduled to release the results for the quarter ended September 30, 2019, tomorrow before the stock market opens. Following the release, the company will host a telephone conference at 2:00 p.m. We expect to see continued strong growth, driven by increasing sales related to warm perfusion.

AN

Arvid Necander

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.